DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY 2026 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.400-1.500 for the period, compared to the consensus earnings per share estimate of 1.490. The company issued revenue guidance of $3.5 billion-$3.6 billion, compared to the consensus revenue estimate of $3.7 billion.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.09 during midday trading on Thursday, hitting $12.71. The company had a trading volume of 6,878,332 shares, compared to its average volume of 4,692,243. The firm has a 50-day moving average price of $12.32 and a 200-day moving average price of $12.47. The company has a market capitalization of $2.54 billion, a PE ratio of -2.88, a P/E/G ratio of 1.03 and a beta of 1.01. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36. DENTSPLY SIRONA has a twelve month low of $9.85 and a twelve month high of $19.03.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). The company had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were given a $0.16 dividend. The ex-dividend date was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. DENTSPLY SIRONA’s payout ratio is presently -14.48%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and set a $14.00 price target on shares of DENTSPLY SIRONA in a report on Monday, January 5th. JPMorgan Chase & Co. cut their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Barclays began coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. Finally, Bank of America upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lifted their target price for the company from $13.00 to $17.00 in a research report on Thursday, February 19th. Three investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $14.46.

Insider Buying and Selling

In other news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.50% of the company’s stock.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Caitong International Asset Management Co. Ltd raised its position in shares of DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,122 shares in the last quarter. Kestra Advisory Services LLC acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $56,000. Persistent Asset Partners Ltd acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $98,000. Finally, Pitcairn Co. bought a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at about $160,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.